Commons Capital
VC Fund
Brookline, United States
Commons Capital is an early-stage venture capital fund focused on clean energy, environment, education, and healthcare sectors.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Commons Capital invests in
Stages Commons Capital invests in
Countries Commons Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
William Osborn
|
|||
Investment Focus
Industry
- Health Care 3 (38%)
- Biotechnology 2 (25%)
- Manufacturing 2 (25%)
- Energy 1 (13%)
- Women's 1 (13%)
Stage
- Series B 4 (50%)
- Series A 2 (25%)
- Funding Round 2 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
William Osborn
Investment Manager
|
Investment Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HistoRx
|
HistoRx is developing theranostic solutions to towards individualized patient care. HistoRx's proprietary technology delivers objective and reproducible multiparametric analysis of proteins in tissue, providing insights into cancer treatment. | $2.6M / May 27, 2011 | |
Combinent Biomedical Systems
|
Combinent Biomedical Systems, Inc., a women's healthcare company, offers multi-segmented vaginal rings that allow the delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. It focuses on transvaginal delivery of drugs targeting women's reproductive endocrinology disorders, as well as diabetes, obesity, andinfectious diseases. Combinent Biomedical Systems, Inc. was incorporated in 2000 and is based in Lexington, Massachusetts. | $500K / Dec 17, 2009 | |
Claros Diagnostics
|
Claros Diagnostics, Inc. is creating products to move in-vitro medical diagnostic tests out of the laboratory and into the hands of physicians and patients. | $4M / Series B / Mar 23, 2009 | |
|
HistoRx
|
HistoRx is developing theranostic solutions to towards individualized patient care. HistoRx's proprietary technology delivers objective and reproducible multiparametric analysis of proteins in tissue, providing insights into cancer treatment. | $6M / Series B / Oct 24, 2007 | |
|
Claros Diagnostics
|
Claros Diagnostics, Inc. is creating products to move in-vitro medical diagnostic tests out of the laboratory and into the hands of physicians and patients. | $7.8M / Series A / Jan 19, 2007 | |
Protonex Technology Corporation
|
Protonex is opening up a world of new energy by revolutionizing the way you can use portable power. Tap into tomorrow's power today and find the product that best suits your changing portable power needs. Protonex power solutions offer numerous advantages over batteries and generators | $9M / Series B / Apr 04, 2005 | |
Medical Metrx Solutions
|
Medical Metrx Solutions, Inc. (formerly Medical Media Systems) is a medical technology and services company providing diagnostic quality 3-D virtual models of patient anatomy built from CT and MR scan data using the company’s proprietary modeling software. The company’s models — which contain more precise quantitative measurement informationthan competitors’ offerings — are provided to interventional radiologists and vascular surgeons who use them for pre-operative planning and post-operative surveillance of their patients’ conditions. The company was acquired by AIG Altaris Health Partners in 2005. | $3.5M / Series B / Dec 17, 2003 | |
H2Gen Innovations
|
H2Gen Innovations, Inc., of Alexandria , Virginia develops, manufactures and markets on-site hydrogen appliances that provide a significant breakthrough for the existing industrial hydrogen market and will be a key enabling technology for the emerging hydrogen economy. The H2Gen hydrogen generator module (HGM) converts natural gas to hydrogenusing a unique steam methane reformer, producing 2,000 scf/hr. of up to “five nines” pure hydrogen. The all-in cost of hydrogen produced with the HGM at the point of delivery is 35% to 65% less than existing conventional methods of producing and delivering hydrogen to target end-use customers. They believe that they have the superior technology for on-site hydrogen production in regard to output, purity and price for a remarkably small appliance. The company was formed in February 2001 by a team of engineers who saw the market opportunity, and who had been working on the concept and technology for the preceding seven years. | $4.7M / Series A / Oct 09, 2001 |
Co-Investors
Accelerated Technologies Partners
2 deals together
Bioventures Investors
2 deals together
Brook Venture Partners
2 deals together
Maven Capital Partners
2 deals together
Navigator Technology Ventures
2 deals together
Oxford Bioscience Partners
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Commons Capital invest in?
Commons Capital invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series B and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Commons Capital?
Public channels for Commons Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Commons Capital?
The team at Commons Capital includes William Osborn (Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
